http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112012020060-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fabb648be4bafcf594cc085f6a5495c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
| filingDate | 2011-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33c33d8fae7007dc21e5e5aa68b8b16a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da17c0c1db81be578bcb848404b6a06d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26cccae1e8d6993804c505984f994466 |
| publicationDate | 2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-112012020060-B1 |
| titleOfInvention | USE OF N-((1-((4-HYDROXITETRAHYDRO-2H-PIRAN-4-YL)METHYL)PIPERIDIN-4-YL)METHYL)-3-ISOPROPYL-2-OXO-2,3-DIHYDRO-1H-BENZO [D]ImidAZOLE-1-CARBOXAMIDE TO TREAT ALZHEIMER'S DISEASE AND DEMENTIA |
| abstract | COMPOUNDS OF FORMULA (I) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, USE OF THE SAME IN THE MANUFACTURING OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF DEMENTIA IN AN ANIMAL SUBJECT INCLUDING A MAMMALIAN SUBJECT This invention of formula relates to a compound (I) or a pharmaceutically acceptable salt thereof with 5-HT4 agonistic activities, which is useful in the treatment of dementia. This invention also relates to a pharmaceutical composition for the treatment of dementia which comprises a therapeutically amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof. Additionally, this invention relates to a method of treating dementia in an animal subject including a mammalian subject, which comprises administering to the animal subject including a mammalian subject a compound of formula (I) or a pharmaceutically acceptable salt thereof. . |
| priorityDate | 2010-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 257.